Hsp90 pan and Isoform-Selective Inhibitors as Sensitizers for Cancer Immunotherapy is a research paper published in Pharmaceuticals (2025). On theSindex it has a DataRank of 0. It has been cited 7 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: R01CA297220
National Institutes of Health
Grant: R01CA248033
National Institutes of Health
Grant: R01CA280097
National Institutes of Health
Grant: W81XWH2010312
National Institutes of Health
Grant: HT94252310010
National Institutes of Health
Grant: HT94252310613
Boler Family Foundation
Grant: n/a
National Institutes of Health
Grant: 5R01CA248033-04
Converting Cold to Hot Tumor Microenvironment in Prostate Cancer by Targeting Chromatin Effector
National Institutes of Health
Grant: 1R01CA280097-01
Immunosuppression and Metabolic Rewiring in Tumor-infiltrating Neutrophils
National Institutes of Health
Grant: 1R01CA297220-01A1
Developing isoform-selective Hsp90 inhibitors for monotherapy and enhanced immunotherapy against lethal prostate cancer
FWCI
2.92
Citation Percentile
0.9%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals